Dirk Jan Hijnen

Dirk Jan Hijnen serves as a Researcher in the Department of Dermatology at Erasmus MC, part of the Faculty of Medicine at this prominent Dutch medical institution. His academic profile demonstrates extensive engagement in clinical dermatological research with particular emphasis on inflammatory skin conditions.

Dr. Hijnen's research interests center around atopic dermatitis (100% fingerprint match), severe acute respiratory syndrome coronavirus 2 (48%), immune-mediated inflammatory diseases (34%), disease activity monitoring (24%), eczema (24%), immunosuppressant therapies (22%), dupilumab (19%), and pruritus (19%). His work bridges clinical dermatology with immunological research, particularly examining how immunosuppressed patients respond to infections like SARS-CoV-2.

Analysis of his recent publications reveals a strong focus on treatment outcomes for inflammatory skin conditions, with significant contributions to understanding systemic treatments for lichen planopilaris and frontal fibrosing alopecia, drug survival analyses for new atopic dermatitis agents, and practical clinical guidance on Janus kinase inhibitors. His work demonstrates consistent attention to real-world clinical practice patterns and therapeutic efficacy.

Dr. Hijnen has contributed to 120 research outputs including 92 articles, 13 comment/letters to the editor, 8 meeting abstracts, 5 review articles, and other scholarly contributions. His research has been disseminated through prominent dermatological journals including Acta Dermato-Venereologica, Journal of Cosmetic Dermatology, and British Journal of Dermatology.

He has participated in collaborative research networks, including the T2B! Immunity against SARS-CoV-2 study group, and has contributed to international guidelines through the International Eczema Council. His work has garnered attention across academic platforms with readership on Mendeley, mentions in news outlets, and social media engagement.